Therapeutic follow-up observational study and population kinetics ancillary study of valproate microgranules [valproic acid] (Micropakine SR) in patients aged between 6 months and 15 years suffering from epilepsy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Valproic acid (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Pharmacokinetics
- Acronyms VAPOP
- 13 Oct 2009 Actual patient number changed from 82 to 81 as reported by ClinicalTrials.gov.
- 06 Oct 2009 Biomarkers information updated
- 06 Mar 2009 Actual patient number (82) added as reported by ClinicalTrials.gov.